You must be new here.
there's plenty of evidence.
i can go on about multiplicity, p values, null hypotheses, it's been discussed here ad infinitum.
i don't have the time to reply to all of your doom and gloom.
FDA are placing msb to a higher standard, which is a given, once approved there will be a rush of other therapeutic companies lining up for FDA approval.
first of its kind, blah blah blah
we've seen a large amount of other drugs bring approved with less data.
eye on the prize
You must be new here.there's plenty of evidence.i can go on...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
0.015(1.40%) |
Mkt cap ! $1.238B | |||
| Open | High | Low | Value | Volume |
| $1.11 | $1.12 | $1.08 | $11.51M | 10.52M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 17804 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 230637 | 5 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.09 |
Change
0.015 ( 1.85 %) |
||||
| Open | High | Low | Volume | ||
| $1.10 | $1.12 | $1.08 | 1937390 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| MSB (ASX) Chart |